Sexual dysfunctions (SD) are often associated to psychiatric disorders, either as part of the psychopathology, or as adverse effect of psychotropic medication. When sexual complains are secondary to the clinical condition, it is expected to remit with treatment. Substance-induced sexual dysfunctions, on the other hand, tend to persist, even after pharmacotherapy is over, with deleterious impact in sexual function. Therefore, it is plausible to affirm that a significant number of patients in psychiatric settings, and even a relevant percentage of the general population, will be exposed to the deleterious effects of psychotropic medication in sexual function 1 . These problems deeply affect patients' and partners' sexual satisfaction, threatening relationship stability and partnership-related quality of life aspects. It also negatively impacts pharmacotherapy adherence, thus affecting therapeutic outcomes 2 .
rarely mentioned and poorly evaluated in terms of feasibility and efficacy.
There is also a potential preventive role of early detection and intervention in cognitive sexual vulnerability still to be explored. Imagine if practitioners could count, since baseline, on a decision algorithm to inform whether that single patient would present an increased risk for developing sexual complains and if that would be a disturbing factor to pharmacotherapy adherence. It is also likely that other aspects of sexuality -such as gender, sexual roles and sexual cognitions -, play an important part in the development and maintenance of substance induced SD, as well as in its burden in treatment and patient's quality of life 12 . Psychotherapy sexual interventions in prevention and/or treatment of SD in psychiatric settings is, therefore, a promising research area, resting to be further explored.
Cognitive-behavioral therapy is recognized by its efforts in developing and providing evidence-based psychotherapeutic interventions to various kinds of psychological and interpersonal problems, being this ideological standpoint a trigger to continuous actualization of its theory and practice. Cognitive sexual therapy (CST) is a cognitive-behavioral integrative psychotherapy aimed specifically to address and treat SDs, articulating evidencebased clinical interventions to scientific understandings of human sexuality 13 . In a CST perspective, distorted sexual cognitions, allied to individuals´ misinterpretations of sexual demands, directly affect emotional, physiological and behavioral regulation in sexual situations. In this sense, restructuring central and intermediate cognitive processes is essential to foster the acquisition of sexual skills and to promote the development of a more adapted sexual repertoire. Thus, cognitions are understood as mediating factors to be modified, aiming sexual skills implementation and emotional regulation during sexual encounters.
Being able to flexibilize sexual scripts and behaviors leads to better adaptation to physiological, environmental and relational changes that negatively impact sexuality over the life cycle, contributing to booster sexual satisfaction even in the presence of sexual function disturbances. The focus of CST interventions is this population would be to aid patients and partners towards the development of more flexible and adaptable sexual cognitions and behavioral patterns. That could permit regain sexual function and satisfaction along and after treatment with psychotropic medication, lessen the negative impact of sexual adverse effects in quality of life and therefore, increase adherence and therapeutic effects of pharmacotherapy. Although the theoretical rationale supporting this proposal is evidence-based, feasibility, efficacy, treatment modalities and procedural aspects of the intervention remain to be empirically tested.
